Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Detection of Rectal Chlamydia trachomatis in Heterosexual Men Who Report Cunnilingus.

Batteiger TA, Jordan SJ, Toh E, Fortenberry L, Williams JA, LaPradd M, Katz B, Fortenberry JD, Dodge B, Arno J, Batteiger BE, Nelson DE.

Sex Transm Dis. 2019 Jul;46(7):440-445. doi: 10.1097/OLQ.0000000000000998.

PMID:
31194715
2.

Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.

Taylor SN, Marrazzo J, Batteiger BE, Hook EW 3rd, Seña AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, Mueller J.

N Engl J Med. 2018 Nov 8;379(19):1835-1845. doi: 10.1056/NEJMoa1706988.

PMID:
30403954
3.

Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation.

Taylor SN, Morris DH, Avery AK, Workowski KA, Batteiger BE, Tiffany CA, Perry CR, Raychaudhuri A, Scangarella-Oman NE, Hossain M, Dumont EF.

Clin Infect Dis. 2018 Aug 1;67(4):504-512. doi: 10.1093/cid/ciy145.

4.

Azithromycin Efficacy in Asymptomatic Rectal Chlamydial Infection in Men Who Have Sex With Men: A More Definitive Answer Soon?

Batteiger BE.

Sex Transm Dis. 2017 Jul;44(7):403-405. doi: 10.1097/OLQ.0000000000000639. No abstract available.

5.

Neisseria meningitidis ST11 Complex Isolates Associated with Nongonococcal Urethritis, Indiana, USA, 2015-2016.

Toh E, Gangaiah D, Batteiger BE, Williams JA, Arno JN, Tai A, Batteiger TA, Nelson DE.

Emerg Infect Dis. 2017 Feb;23(2):336-339. doi: 10.3201/eid2302.161434.

6.

Genotype-Specific Concordance of Chlamydia trachomatis Genital Infection Within Heterosexual Partnerships.

Schillinger JA, Katz BP, Markowitz LE, Braslins PG, Shrier LA, Madico G, Van Der Pol B, Orr DP, Rice PA, Batteiger BE.

Sex Transm Dis. 2016 Dec;43(12):741-749.

7.

Reconsidering the Use of Azithromycin for Chlamydial Urethritis.

Dombrowski JC, Batteiger BE.

Sex Transm Dis. 2016 Oct;43(10):603-4. doi: 10.1097/OLQ.0000000000000519. No abstract available.

PMID:
27626187
8.

Novel Chlamydia trachomatis strains in heterosexual sex partners, Indianapolis, Indiana, USA.

Batteiger BE, Wan R, Williams JA, He L, Ma A, Fortenberry JD, Dean D.

Emerg Infect Dis. 2014 Nov;20(11):1841-7. doi: 10.3201/2011.140604.

9.

Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women.

Geisler WM, Pascual ML, Mathew J, Koltun WD, Morgan F, Batteiger BE, Mayes A, Tao S, Hurwitz SJ, Sayada C, Schinazi RF.

Antimicrob Agents Chemother. 2014 Jul;58(7):4014-9. doi: 10.1128/AAC.02521-14. Epub 2014 May 5.

10.

Duration of polymerase chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women.

Williams JA, Ofner S, Batteiger BE, Fortenberry JD, Van Der Pol B.

Sex Transm Dis. 2014 Mar;41(3):215-9. doi: 10.1097/OLQ.0000000000000102.

PMID:
24521729
11.

Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial.

Geisler WM, Koltun WD, Abdelsayed N, Burigo J, Mena L, Taylor SN, Batteiger BE, Thurman AR, Hook EW 3rd, Vaughn TA, Annett MP, Muenzen RA, Caminis J.

Clin Infect Dis. 2012 Jul;55(1):82-8. doi: 10.1093/cid/cis291. Epub 2012 Mar 19.

PMID:
22431798
12.

Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Batteiger BE, Xu F, Johnson RE, Rekart ML.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S178-89. Review.

13.

Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women.

Tu W, Batteiger BE, Wiehe S, Ofner S, Van Der Pol B, Katz BP, Orr DP, Fortenberry JD.

Arch Pediatr Adolesc Med. 2009 Dec;163(12):1106-11. doi: 10.1001/archpediatrics.2009.203.

14.

Repeated Chlamydia trachomatis genital infections in adolescent women.

Batteiger BE, Tu W, Ofner S, Van Der Pol B, Stothard DR, Orr DP, Katz BP, Fortenberry JD.

J Infect Dis. 2010 Jan 1;201(1):42-51. doi: 10.1086/648734.

15.

Depressive symptoms and sexual risk behavior in young, chlamydia-infected, heterosexual dyads.

Shrier LA, Schillinger JA, Aneja P, Rice PA, Batteiger BE, Braslins PG, Orr DP, Fortenberry JD.

J Adolesc Health. 2009 Jul;45(1):63-9. doi: 10.1016/j.jadohealth.2008.11.016. Epub 2009 Feb 20.

PMID:
19541251
16.

Mycoplasma genitalium among adolescent women and their partners.

Tosh AK, Van Der Pol B, Fortenberry JD, Williams JA, Katz BP, Batteiger BE, Orr DP.

J Adolesc Health. 2007 May;40(5):412-7. Epub 2007 Feb 15.

17.

A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men.

Stamm WE, Batteiger BE, McCormack WM, Totten PA, Sternlicht A, Kivel NM; Rifalazil Study Group.

Sex Transm Dis. 2007 Aug;34(8):545-52.

PMID:
17297383
18.

Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women.

Shew ML, Fortenberry JD, Tu W, Juliar BE, Batteiger BE, Qadadri B, Brown DR.

Arch Pediatr Adolesc Med. 2006 Feb;160(2):151-6.

PMID:
16461870
19.

Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.

Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD.

J Infect Dis. 2005 Dec 15;192(12):2039-44. Epub 2005 Nov 8.

PMID:
16288365
20.

Gender differences in sexual behaviours in response to genitourinary symptoms.

Khan A, Fortenberry JD, Temkit MH, Tu W, Orr DP, Batteiger BE.

Sex Transm Infect. 2005 Jun;81(3):262-6.

21.

The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment.

Khan A, Fortenberry JD, Juliar BE, Tu W, Orr DP, Batteiger BE.

Sex Transm Dis. 2005 Apr;32(4):260-4.

22.

Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens.

Huppert JS, Batteiger BE, Braslins P, Feldman JA, Hobbs MM, Sankey HZ, Sena AC, Wendel KA.

J Clin Microbiol. 2005 Feb;43(2):684-7.

23.
24.

Evaluation of the Digene Hybrid Capture II Assay with the Rapid Capture System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Van Der Pol B, Williams JA, Smith NJ, Batteiger BE, Cullen AP, Erdman H, Edens T, Davis K, Salim-Hammad H, Chou VW, Scearce L, Blutman J, Payne WJ.

J Clin Microbiol. 2002 Oct;40(10):3558-64.

25.

Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program.

Frank MO, Batteiger BE, Sorensen SJ, Hartstein AI, Carr JA, McComb JS, Clark CD, Abel SR, Mikuta JM, Jones RB.

Clin Perform Qual Health Care. 1997 Oct-Dec;5(4):180-8.

PMID:
10176026
28.

Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study.

Stamm WE, Hicks CB, Martin DH, Leone P, Hook EW 3rd, Cooper RH, Cohen MS, Batteiger BE, Workowski K, McCormack WM.

JAMA. 1995 Aug 16;274(7):545-9.

PMID:
7629982
29.

Age and clinical immunity to infections with Chlamydia trachomatis.

Arno JN, Katz BP, McBride R, Carty GA, Batteiger BE, Caine VA, Jones RB.

Sex Transm Dis. 1994 Jan-Feb;21(1):47-52.

PMID:
8140489
31.

Recurrent genitourinary chlamydial infections in sexually active female adolescents.

Blythe MJ, Katz BP, Batteiger BE, Ganser JA, Jones RB.

J Pediatr. 1992 Sep;121(3):487-93.

PMID:
1517932
32.

Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis.

Hooton TM, Batteiger BE, Judson FN, Spruance SL, Stamm WE.

Antimicrob Agents Chemother. 1992 May;36(5):1144-6.

33.
34.

Interferon-gamma in endocervical secretions of women infected with Chlamydia trachomatis.

Arno JN, Ricker VA, Batteiger BE, Katz BP, Caine VA, Jones RB.

J Infect Dis. 1990 Dec;162(6):1385-9.

PMID:
2121840
36.

Histoplasma capsulatum infections of the central nervous system. A clinical review.

Wheat LJ, Batteiger BE, Sathapatayavongs B.

Medicine (Baltimore). 1990 Jul;69(4):244-60. Review.

PMID:
2197524
37.

Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease.

Batteiger BE, Jones RB, White A.

Am J Med. 1989 Dec 29;87(6C):75S-77S.

PMID:
2603894
38.

Correlation of infecting serovar and local inflammation in genital chlamydial infections.

Batteiger BE, Lennington W, Newhall WJ, Katz BP, Morrison HT, Jones RB.

J Infect Dis. 1989 Aug;160(2):332-6.

PMID:
2760488
39.

Association of recurrent chlamydial infection with gonorrhea.

Batteiger BE, Fraiz J, Newhall WJ, Katz BP, Jones RB.

J Infect Dis. 1989 Apr;159(4):661-9.

PMID:
2926160
41.

Protective role of serum antibody in immunity to chlamydial genital infection.

Rank RG, Batteiger BE.

Infect Immun. 1989 Jan;57(1):299-301.

42.

Susceptibility to reinfection after a primary chlamydial genital infection.

Rank RG, Batteiger BE, Soderberg LS.

Infect Immun. 1988 Sep;56(9):2243-9.

43.
44.

Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis.

Katz BP, Batteiger BE, Jones RB.

Sex Transm Dis. 1987 Jul-Sep;14(3):160-4.

PMID:
3660170
45.

Chlamydial infections.

Batteiger BE, Jones RB.

Infect Dis Clin North Am. 1987 Mar;1(1):55-81. Review.

PMID:
3332789
46.

Effect of blind passage and multiple sampling on recovery of Chlamydia trachomatis from urogenital specimens.

Jones RB, Katz BP, van der Pol B, Caine VA, Batteiger BE, Newhall WJ.

J Clin Microbiol. 1986 Dec;24(6):1029-33.

47.

Antigenic analysis of the major outer membrane protein of Chlamydia trachomatis with murine monoclonal antibodies.

Batteiger BE, Newhall WJ 5th, Terho P, Wilde CE 3rd, Jones RB.

Infect Immun. 1986 Sep;53(3):530-3.

48.

Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies.

Newhall WJ 5th, Terho P, Wilde CE 3rd, Batteiger BE, Jones RB.

J Clin Microbiol. 1986 Feb;23(2):333-8.

49.
50.

Hepatitis B virus vaccine: a randomized trial of a reduced dose regimen in hemodialysis patients.

Aronoff GR, Maxwell DR, Batteiger BE, Fineberg NS.

Am J Kidney Dis. 1985 Sep;6(3):170-2.

PMID:
3898825

Supplemental Content

Loading ...
Support Center